rs398124200
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2
The NM_005120.3(MED12):c.6348_6359dup(p.His2116_Gln2119dup) variant causes a inframe insertion change. The variant allele was found at a frequency of 0.0258 in 1,163,774 control chromosomes in the GnomAD database, including 382 homozygotes. There are 9,478 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q2113Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_005120.3 inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MED12 | NM_005120.3 | c.6348_6359dup | p.His2116_Gln2119dup | inframe_insertion | 43/45 | ENST00000374080.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MED12 | ENST00000374080.8 | c.6348_6359dup | p.His2116_Gln2119dup | inframe_insertion | 43/45 | 1 | NM_005120.3 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.0222 AC: 2458AN: 110863Hom.: 26 Cov.: 22 AF XY: 0.0195 AC XY: 647AN XY: 33233
GnomAD3 exomes AF: 0.0232 AC: 2640AN: 113704Hom.: 47 AF XY: 0.0221 AC XY: 897AN XY: 40594
GnomAD4 exome AF: 0.0261 AC: 27509AN: 1052857Hom.: 356 Cov.: 33 AF XY: 0.0257 AC XY: 8829AN XY: 343977
GnomAD4 genome ? AF: 0.0222 AC: 2459AN: 110917Hom.: 26 Cov.: 22 AF XY: 0.0195 AC XY: 649AN XY: 33297
ClinVar
Submissions by phenotype
not specified Benign:7
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 29, 2015 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 09, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Oct 31, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | This variant was found in TAADV2-PANCARD,TAAD,TAADV2-1,MACRO-BRAIN - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
FG syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2017 | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance;Other strong data supporting benign classification - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at